The War on Cancer, 40 years later

Friday, December 23, marks the 40th anniversary of President Richard Nixon’s declaration of a national “War on Cancer.” On that date in 1971, Nixon signed the National Cancer Act, which allocated $1.5 billion over three years for cancer research and control. He declared, “I hope that in the years ahead we may look back on … Read more

Blood cancer research may lead to new treatments

At this year’s American Society of Hematology Annual Meeting, Dana-Farber scientists presented major findings that could one day improve diagnosis and treatment of blood cancers, extend life, or even cure some diseases. Among the highlights: Steven Treon, MD, PhD, and his colleagues identified a gene mutation that underlies the vast majority of cases of Waldenström’s … Read more

Breast cancer specialist discusses treatment advances

Harold J. Burstein, MD, PhD, a Dana-Farber breast cancer specialist, discusses some of the important studies presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. The five-day meeting includes more than 1,000 scientific presentations, seminars, and posters, with a focus on emerging treatments in hard-to-treat populations, patients with metastatic breast cancer, and breast cancer … Read more

Author Siddhartha Mukherjee: “Cancer is a part of us”

Siddhartha Mukherjee, MD, PhD, was a postdoctoral fellow at Dana-Farber in 2003 when one of his patients asked him, “What is it, exactly, that I am battling?” Mukherjee took this simple, yet profound, question seriously. The answer formed the basis for his 2011 Pulitzer Prize-winning book, The Emperor of All Maladies: A Biography of Cancer. … Read more